Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation Development and Evaluation of Orodispersible Tablet of Omeprazole by Using Co-Processed Superdisintegrant


Affiliations
1 Department of Quality Assurance, Rajarambapu College of Pharmacy, Kasegaon, Sangli, India
     

   Subscribe/Renew Journal


In the present study, novel co-processed superdisintegrants were developed by solvent evaporation method using crospovidone and crosscarmellose sodium in different ratios (1:1, 1:3 and 3:1) for use in the fast dissolving tablet formulations. The developed excipients were evaluated for angle of repose, Carr's index and Hausner's ratio in comparison with physical mixture of superdisintegrants. The angle of repose of the developed excipients was found to be <23°, Carr's index in the range of 11-21% and Hausner's ratio in the range of 1.13-1.6. ordispersible tablets of omeprazole were prepared using the above co-processed superdisintegrants and evaluated for pre-compression and post-compression parameters. Based on in vitro dispersion time (approximately 21sec), promising formulation CP1 was tested for in vitro drug release pattern in pH 6.8 Phosphate buffer, drug excipient interaction (IR spectroscopy). Among the designed formulations, the formulation (CP1) containing 6% w/w of co processed superdisintegrant (1:1 mixture of crospovidone and croscarmellose sodium) emerged as the overall best formulation based on drug release characteristics in pH 6.8 phosphate buffer compared to commercial conventional tablet formulation.

Keywords

Co-Processed Super Disintegrant, Omeprazole, ORO Dispersible Tablet, Crospovidone and Croscarmellose Sodium.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 261

PDF Views: 0




  • Formulation Development and Evaluation of Orodispersible Tablet of Omeprazole by Using Co-Processed Superdisintegrant

Abstract Views: 261  |  PDF Views: 0

Authors

Sharad A. More
Department of Quality Assurance, Rajarambapu College of Pharmacy, Kasegaon, Sangli, India
Shrinivas K. Mohite
Department of Quality Assurance, Rajarambapu College of Pharmacy, Kasegaon, Sangli, India

Abstract


In the present study, novel co-processed superdisintegrants were developed by solvent evaporation method using crospovidone and crosscarmellose sodium in different ratios (1:1, 1:3 and 3:1) for use in the fast dissolving tablet formulations. The developed excipients were evaluated for angle of repose, Carr's index and Hausner's ratio in comparison with physical mixture of superdisintegrants. The angle of repose of the developed excipients was found to be <23°, Carr's index in the range of 11-21% and Hausner's ratio in the range of 1.13-1.6. ordispersible tablets of omeprazole were prepared using the above co-processed superdisintegrants and evaluated for pre-compression and post-compression parameters. Based on in vitro dispersion time (approximately 21sec), promising formulation CP1 was tested for in vitro drug release pattern in pH 6.8 Phosphate buffer, drug excipient interaction (IR spectroscopy). Among the designed formulations, the formulation (CP1) containing 6% w/w of co processed superdisintegrant (1:1 mixture of crospovidone and croscarmellose sodium) emerged as the overall best formulation based on drug release characteristics in pH 6.8 phosphate buffer compared to commercial conventional tablet formulation.

Keywords


Co-Processed Super Disintegrant, Omeprazole, ORO Dispersible Tablet, Crospovidone and Croscarmellose Sodium.